Your browser doesn't support javascript.
loading
Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu-Cheney syndrome.
Canalis, Ernesto; Grossman, Tamar R; Carrer, Michele; Schilling, Lauren; Yu, Jungeun.
Affiliation
  • Canalis E; Department of Orthopaedic Surgery, UConn Health, Farmington, Connecticut 06030 canalis@uchc.edu.
  • Grossman TR; Department of Medicine, UConn Health, Farmington, Connecticut 06030.
  • Carrer M; UConn Musculoskeletal Institute, UConn Health, Farmington, Connecticut 06030.
  • Schilling L; Ionis Pharmaceuticals, Inc., Carlsbad, California 92010.
  • Yu J; Ionis Pharmaceuticals, Inc., Carlsbad, California 92010.
J Biol Chem ; 295(12): 3952-3964, 2020 03 20.
Article in En | MEDLINE | ID: mdl-31992595

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides, Antisense / Hajdu-Cheney Syndrome / Receptor, Notch2 Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Biol Chem Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides, Antisense / Hajdu-Cheney Syndrome / Receptor, Notch2 Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Biol Chem Year: 2020 Type: Article